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Highly selective cancer therapeutics with minimal off target effects that preserve patient quality of life are in high 
demand. Towards creating more targeted therapies, advances in bioinformatics and systems biology reinforce 
that cancer is an extremely complex disease, and multiple biomarkers must be considered to exclusively identify 
cancer cells. Furthermore, unique multi-input cancer signatures can vary between cancer subtypes, individual 
patients, and even over time within an individual. To address this, we have developed a flexible platform based 
on synthetic nucleic acid computation for a “smart drug” that can match the complex and dynamic nature of 
cancer. Harnessing the powerful properties of toehold-mediated strand displacement, our technology has the 
ability to control protein assembly through input-triggered nucleic acid circuits. By conjugating DNA to 
fluorescent proteins or a split version of yeast cytosine deaminase, a cancer prodrug activating enzyme, we can 
use nucleic acid computation to control protein behavior for sensing or therapeutic applications, respectively. 
We first created multi-input logic-gated circuits controlled by various cancer-specific miRNA inputs. Realizing the 
limitations that low input concentrations inside cells could place on our protein-DNA devices, we utilized catalytic 
hairpin assembly (CHA) for signal amplification. Next, we integrated both Boolean-logic and amplification 
architectures into a programmable and streamlined design. Moving beyond an in vitro demonstration, we 
executed our protein-DNA computation device in various cancer cells lines that endogenously express cancer-
specific RNA. To our knowledge, this is the first time protein assembly/activity controlled by strand displacement 
computation has been executed inside live mammalian cells, a significant step in realizing the power of nucleic 
acid nanotechnology for future applications. 
 
 
 
